The pet therapeutics company disclosed in a Securities and Exchange Commission filing on Monday that the Food and Drug Administration’s Center for Veterinary Medicine has requested more information about its appetite stimulant Entyce. Specifically, the CVM is looking for additional data related to the company’s plans to transfer the manufacturing of Entyce to a new vendor.